Utility and effectiveness of Symbicort® Turbuhaler® (oral inhalation containing budesonide and formoterol) in a patient with severe asthma after permanent tracheostomy.

Maeda, Kohhei; Yamaguchi, Masao; Nagase, Hiroyuki; Yasuno, Nobuhiro; Itagaki, Fumio; Watanabe, Machiko

Maeda, Kohhei; Yamaguchi, Masao; Nagase, Hiroyuki; Yasuno, Nobuhiro; Itagaki, Fumio; Watanabe, Machiko.

Afiliação

Maeda K; 1Department of Pharmacy, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan.
Yamaguchi M; 2Department of Internal Medicine Division of Respiratory Medicine and Allergology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan.
Nagase H; 2Department of Internal Medicine Division of Respiratory Medicine and Allergology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan.
Yasuno N; 1Department of Pharmacy, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan.
Itagaki F; 1Department of Pharmacy, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan.
Watanabe M; 3Faculty of Pharma Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan.

J Pharm Health Care Sci ; 4: 24, 2018.

Article em En | MEDLINE | ID: mdl-30214819

Palavras-chave

Dry-powder inhaler; Inhalation guidance; Permanent tracheostomy; SMART; Severe asthma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: J Pharm Health Care Sci Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google